Aminocaproic Acid Suppliers & Bulk Manufacturers

Available Forms: Tablets / Oral solution / Injection

Available Strengths: 500 mg, 250 mg/ml

Reference Brands: Amicar(USA)

Category: Critical Care

Aminocaproic Acid is available in Tablets / Oral solution / Injection and strengths such as 500 mg, 250 mg/ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Aminocaproic Acid is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Aminocaproic Acid can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Aminocaproic acid, also known as epsilon-aminocaproic acid or 6-aminohexanoic acid, is a synthetic antifibrinolytic agent and a structural analogue of the amino acid lysine. It works by competitively inhibiting plasminogen activation and blocking the activity of plasmin, the key enzyme responsible for fibrinolysis. By preventing the premature breakdown of fibrin clots, aminocaproic acid helps control and reduce excessive bleeding in patients with increased fibrinolytic activity. It is widely used in clinical settings such as surgical procedures, trauma management, and the treatment of certain bleeding disorders, particularly where abnormal clot dissolution poses a risk.

Aminocaproic acid is marketed under the brand name Amicar in several regions and is available in multiple dosage forms, including tablets, oral solutions, and injectable formulations, making it suitable for both oral and parenteral administration. The drug is primarily utilized in hospital and critical care environments under medical supervision. In addition to its pharmaceutical importance, aminocaproic acid also serves as a chemical intermediate in the manufacture of Nylon-6, where it is produced through the ring-opening hydrolysis of caprolactam. Its well-established mechanism of action, broad clinical utility, and reliable safety profile make aminocaproic acid a valuable agent in bleeding management therapies.